Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
Posted on
September 01, 2010 by
admin
Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
BOTHELL, WA–(Marketwire – 08/30/10) – Marina Biotech, Inc. (NASDAQ: MRNA – News ), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application U.S. 11/745,003 broadly covering amphoteric liposomal formulations, including the Company’s proprietary SMARTICLES technology, for delivery …
Read more on Marketwire via Yahoo! Finance
